Format

Send to

Choose Destination
See comment in PubMed Commons below
Blood Cancer J. 2015 Feb 6;5:e278. doi: 10.1038/bcj.2014.95.

Comprehensive genomic profiling identifies a novel TNKS2-PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy.

Author information

  • 1Foundation Medicine Inc., Cambridge, MA, USA.
  • 2Department of Pathology, Stanford School of Medicine, Stanford, CA, USA.
  • 31] Foundation Medicine Inc., Cambridge, MA, USA [2] Clinical Laboratory, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
  • 4Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
  • 51] Foundation Medicine Inc., Cambridge, MA, USA [2] Department of Pathology and Laboratory Medicine, Albany Medical Center, Albany, NY, USA.
  • 6Northwest Georgia Oncology Centers, Jasper Cancer Center, Jasper, GA, USA.
PMID:
25658984
PMCID:
PMC4349257
DOI:
10.1038/bcj.2014.95
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Support Center